297 related articles for article (PubMed ID: 31870587)
21. Emergence of teicoplanin-resistant coagulase-negative staphylococci.
Cercenado E; García-Leoni ME; Díaz MD; Sánchez-Carrillo C; Catalán P; De Quirós JC; Bouza E
J Clin Microbiol; 1996 Jul; 34(7):1765-8. PubMed ID: 8784585
[TBL] [Abstract][Full Text] [Related]
22. Significance of methicillin-teicoplanin resistant Staphylococcus haemolyticus in bloodstream infections in patients of the Semmelweis University hospitals in Hungary.
Kristóf K; Kocsis E; Szabó D; Kardos S; Cser V; Nagy K; Hermann P; Rozgonyi F
Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):691-9. PubMed ID: 21222010
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
Boisson K; Thouverez M; Talon D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
[TBL] [Abstract][Full Text] [Related]
24. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
Garrett DO; Jochimsen E; Murfitt K; Hill B; McAllister S; Nelson P; Spera RV; Sall RK; Tenover FC; Johnston J; Zimmer B; Jarvis WR
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):167-70. PubMed ID: 10100541
[TBL] [Abstract][Full Text] [Related]
25. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
Bergeret M; Boutros N; Raymond J
Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
[TBL] [Abstract][Full Text] [Related]
26. [Causative agents of intravenous catheter-related infections and their antibiotic susceptibilities].
Aktaş E; Sarı EN; Seremet Keskin A; Pişkin N; Külah C; Cömert F
Mikrobiyol Bul; 2011 Jan; 45(1):86-92. PubMed ID: 21341163
[TBL] [Abstract][Full Text] [Related]
27. Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.
Bertin M; Muller A; Bertrand X; Cornette C; Thouverez M; Talon D
Eur J Clin Microbiol Infect Dis; 2004 May; 23(5):375-9. PubMed ID: 15112071
[TBL] [Abstract][Full Text] [Related]
28. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci.
Tripodi MF; Attanasio V; Adinolfi LE; Florio A; Cione P; Cuccurullo S; Utili R; Ruggiero G
Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):148-52. PubMed ID: 8013488
[TBL] [Abstract][Full Text] [Related]
30. Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin.
Castagnola E; Bandettini R; Lorenzi I; Caviglia I; Macrina G; Tacchella A
Pediatr Infect Dis J; 2010 Nov; 29(11):1047-8. PubMed ID: 20581735
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
[TBL] [Abstract][Full Text] [Related]
32. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.
Sieradzki K; Villari P; Tomasz A
Antimicrob Agents Chemother; 1998 Jan; 42(1):100-7. PubMed ID: 9449268
[TBL] [Abstract][Full Text] [Related]
33. Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.
Poonacha N; Nair S; Desai S; Tuppad D; Hiremath D; Mohan T; Vipra A; Sharma U
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559263
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
[TBL] [Abstract][Full Text] [Related]
36. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
Pham Dang C; Gouin F; Touchais S; Richard C; Potel G
Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia.
Nunes AP; Schuenck RP; Bastos CC; Magnanini MM; Long JB; Iorio NL; Santos KR
Braz J Infect Dis; 2007 Jun; 11(3):345-50. PubMed ID: 17684637
[TBL] [Abstract][Full Text] [Related]
38. Clonal relatedness of methicillin-resistant coagulase-negative staphylococci in the haemodialysis unit of a single university centre in Greece.
Liakopoulos V; Petinaki E; Efthimiadi G; Klapsa D; Giannopoulou M; Dovas S; Eleftheriadis T; Mertens PR; Stefanidis I
Nephrol Dial Transplant; 2008 Aug; 23(8):2599-603. PubMed ID: 18305314
[TBL] [Abstract][Full Text] [Related]
39. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
Hashem AA; Abd El Fadeal NM; Shehata AS
J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
[TBL] [Abstract][Full Text] [Related]
40. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
